CORRECTION article

Front. Pharmacol., 05 September 2023

Sec. Pharmacology of Anti-Cancer Drugs

Volume 14 - 2023 | https://doi.org/10.3389/fphar.2023.1285522

Corrigendum: Bibliometric analysis of evolutionary trends and hotspots of super-enhancers in cancer

  • 1. Department of Neurology, The Second Xiangya Hospital of Central South University, Changsha, China

  • 2. Hunan Key Laboratory of Tumor Models and Individualized Medicine, The Second Xiangya Hospital of Central South University, Changsha, China

  • 3. Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, China

  • 4. National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China

  • 5. Institute of Hospital Management, Central South University, Changsha, China

  • 6. Hunan Key Laboratory of the Research and Development of Novel Pharmaceutical Preparations, Changsha Medical University, Changsha, China

  • 7. Department of Pharmacy, The Second Xiangya Hospital, Institute of Clinical Pharmacy, Central South University, Changsha, China

Article metrics

View details

1,5k

Views

736

Downloads

In the published article, there was an error regarding the affiliation for author Jian Qu. Instead of “Jian Qu6,7*” it should be “Jian Qu7*”. Jian Qu’s correct affiliation is “7Department of Pharmacy, The Second Xiangya Hospital, Institute of Clinical Pharmacy, Central South University, Changsha, China” and the following affiliation is incorrect and should be removed “6Hunan Key Laboratory of the Research and Development of Novel Pharmaceutical Preparations, Changsha Medical University, Changsha, China”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

super-enhancer, bibliometric analysis, cancer, hot spots, trends

Citation

Tang Z-C, Qu Q, Teng X-Q, Zhuang H-H, Xu W-X and Qu J (2023) Corrigendum: Bibliometric analysis of evolutionary trends and hotspots of super-enhancers in cancer. Front. Pharmacol. 14:1285522. doi: 10.3389/fphar.2023.1285522

Received

30 August 2023

Accepted

31 August 2023

Published

05 September 2023

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

14 - 2023

Updates

Copyright

*Correspondence: Jian Qu,

†These authors have contributed equally to this work

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics